Australia markets closed

Tempest Therapeutics Inc (3OS.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
3.0380-0.2420 (-7.38%)
At close: 08:08PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-29,491
-29,491
-35,709
-28,302
-19,208
Depreciation & amortisation
381
381
638
374
339
Stock-based compensation
2,546
2,546
1,561
1,105
453
Change in working capital
-2,677
-2,677
868
-613
-1,071
Accounts payable
-263
-263
1
-209
-574
Other working capital
-27,527
-27,527
-31,634
-26,092
-19,067
Other non-cash items
1,884
1,884
1,570
1,479
470
Net cash provided by operating activities
-27,357
-27,357
-31,072
-25,957
-19,017
Cash flows from investing activities
Investments in property, plant and equipment
-170
-170
-562
-135
-50
Other investing activities
-
-
-
38
44
Net cash used for investing activities
-170
-170
-562
-97
-6
Cash flows from financing activities
Debt repayment
0
0
-4,739
0
-
Common stock issued
35,602
35,602
8,861
33,425
0
Other financing activities
-
-
-
10,530
-470
Net cash used provided by (used for) financing activities
35,602
35,602
11,403
59,063
34,599
Net change in cash
8,075
8,075
-20,231
33,009
15,576
Cash at beginning of period
31,598
31,598
51,829
18,820
3,244
Cash at end of period
39,673
39,673
31,598
51,829
18,820
Free cash flow
Operating cash flow
-27,357
-27,357
-31,072
-25,957
-19,017
Capital expenditure
-170
-170
-562
-135
-50
Free cash flow
-27,527
-27,527
-31,634
-26,092
-19,067